 | • レポートコード：MRC2-11QY11269 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は心筋症のグローバル市場について調査・分析したレポートです。種類別（拡張型心筋症、肥大型心筋症、拘束型心筋症）市場規模、用途別（病院・診断センター、外来サービスセンター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別心筋症の競争状況、市場シェア ・世界の心筋症市場：種類別市場規模 2015年-2020年（拡張型心筋症、肥大型心筋症、拘束型心筋症） ・世界の心筋症市場：種類別市場規模予測 2021年-2026年（拡張型心筋症、肥大型心筋症、拘束型心筋症） ・世界の心筋症市場：用途別市場規模 2015年-2020年（病院・診断センター、外来サービスセンター） ・世界の心筋症市場：用途別市場規模予測 2021年-2026年（病院・診断センター、外来サービスセンター） ・北米の心筋症市場分析：米国、カナダ ・ヨーロッパの心筋症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの心筋症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の心筋症市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの心筋症市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Array BioPharma、Boston Scientific、Cisbio、Covance、Critical Diagnostics、Mylan、Pfizer、Becton Dickinson、BG Medicine、BioMérieux、Bio-Rad ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cardiomyopathy refers to diseases of the heart muscle
The major factors that contributes in the growth of the market are advancement in understanding and managing cardiomyopathy and rise in incidences of congestive heart failure, coronary heart disease, and heart attack. Further, increasing trend of minimally invasive technology and availability of remote monitoring solutions are estimated to contribute in the growth of the market.
Market Analysis and Insights: Global Cardiomyopathy Market
The global Cardiomyopathy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cardiomyopathy Scope and Market Size
Cardiomyopathy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cardiomyopathy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Array BioPharma
Boston Scientific
Cisbio
Covance
Critical Diagnostics
Mylan
Pfizer
Becton Dickinson
BG Medicine
BioMérieux
Bio-Rad
Market segment by Type, the product can be split into
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
Market segment by Application, split into
Hospitals and diagnostic centers
Ambulatory services centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cardiomyopathy Revenue
1.4 Market by Type
1.4.1 Global Cardiomyopathy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Dilated cardiomyopathy
1.4.3 Hypertrophic cardiomyopathy
1.4.4 Restrictive cardiomyopathy
1.5 Market by Application
1.5.1 Global Cardiomyopathy Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and diagnostic centers
1.5.3 Ambulatory services centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cardiomyopathy Market Perspective (2015-2026)
2.2 Global Cardiomyopathy Growth Trends by Regions
2.2.1 Cardiomyopathy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cardiomyopathy Historic Market Share by Regions (2015-2020)
2.2.3 Cardiomyopathy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cardiomyopathy Market Growth Strategy
2.3.6 Primary Interviews with Key Cardiomyopathy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cardiomyopathy Players by Market Size
3.1.1 Global Top Cardiomyopathy Players by Revenue (2015-2020)
3.1.2 Global Cardiomyopathy Revenue Market Share by Players (2015-2020)
3.1.3 Global Cardiomyopathy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cardiomyopathy Market Concentration Ratio
3.2.1 Global Cardiomyopathy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cardiomyopathy Revenue in 2019
3.3 Cardiomyopathy Key Players Head office and Area Served
3.4 Key Players Cardiomyopathy Product Solution and Service
3.5 Date of Enter into Cardiomyopathy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cardiomyopathy Historic Market Size by Type (2015-2020)
4.2 Global Cardiomyopathy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cardiomyopathy Market Size by Application (2015-2020)
5.2 Global Cardiomyopathy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cardiomyopathy Market Size (2015-2020)
6.2 Cardiomyopathy Key Players in North America (2019-2020)
6.3 North America Cardiomyopathy Market Size by Type (2015-2020)
6.4 North America Cardiomyopathy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cardiomyopathy Market Size (2015-2020)
7.2 Cardiomyopathy Key Players in Europe (2019-2020)
7.3 Europe Cardiomyopathy Market Size by Type (2015-2020)
7.4 Europe Cardiomyopathy Market Size by Application (2015-2020)
8 China
8.1 China Cardiomyopathy Market Size (2015-2020)
8.2 Cardiomyopathy Key Players in China (2019-2020)
8.3 China Cardiomyopathy Market Size by Type (2015-2020)
8.4 China Cardiomyopathy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cardiomyopathy Market Size (2015-2020)
9.2 Cardiomyopathy Key Players in Japan (2019-2020)
9.3 Japan Cardiomyopathy Market Size by Type (2015-2020)
9.4 Japan Cardiomyopathy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cardiomyopathy Market Size (2015-2020)
10.2 Cardiomyopathy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cardiomyopathy Market Size by Type (2015-2020)
10.4 Southeast Asia Cardiomyopathy Market Size by Application (2015-2020)
11 India
11.1 India Cardiomyopathy Market Size (2015-2020)
11.2 Cardiomyopathy Key Players in India (2019-2020)
11.3 India Cardiomyopathy Market Size by Type (2015-2020)
11.4 India Cardiomyopathy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cardiomyopathy Market Size (2015-2020)
12.2 Cardiomyopathy Key Players in Central & South America (2019-2020)
12.3 Central & South America Cardiomyopathy Market Size by Type (2015-2020)
12.4 Central & South America Cardiomyopathy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Array BioPharma
13.1.1 Array BioPharma Company Details
13.1.2 Array BioPharma Business Overview
13.1.3 Array BioPharma Cardiomyopathy Introduction
13.1.4 Array BioPharma Revenue in Cardiomyopathy Business (2015-2020))
13.1.5 Array BioPharma Recent Development
13.2 Boston Scientific
13.2.1 Boston Scientific Company Details
13.2.2 Boston Scientific Business Overview
13.2.3 Boston Scientific Cardiomyopathy Introduction
13.2.4 Boston Scientific Revenue in Cardiomyopathy Business (2015-2020)
13.2.5 Boston Scientific Recent Development
13.3 Cisbio
13.3.1 Cisbio Company Details
13.3.2 Cisbio Business Overview
13.3.3 Cisbio Cardiomyopathy Introduction
13.3.4 Cisbio Revenue in Cardiomyopathy Business (2015-2020)
13.3.5 Cisbio Recent Development
13.4 Covance
13.4.1 Covance Company Details
13.4.2 Covance Business Overview
13.4.3 Covance Cardiomyopathy Introduction
13.4.4 Covance Revenue in Cardiomyopathy Business (2015-2020)
13.4.5 Covance Recent Development
13.5 Critical Diagnostics
13.5.1 Critical Diagnostics Company Details
13.5.2 Critical Diagnostics Business Overview
13.5.3 Critical Diagnostics Cardiomyopathy Introduction
13.5.4 Critical Diagnostics Revenue in Cardiomyopathy Business (2015-2020)
13.5.5 Critical Diagnostics Recent Development
13.6 Mylan
13.6.1 Mylan Company Details
13.6.2 Mylan Business Overview
13.6.3 Mylan Cardiomyopathy Introduction
13.6.4 Mylan Revenue in Cardiomyopathy Business (2015-2020)
13.6.5 Mylan Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Cardiomyopathy Introduction
13.7.4 Pfizer Revenue in Cardiomyopathy Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Becton Dickinson
13.8.1 Becton Dickinson Company Details
13.8.2 Becton Dickinson Business Overview
13.8.3 Becton Dickinson Cardiomyopathy Introduction
13.8.4 Becton Dickinson Revenue in Cardiomyopathy Business (2015-2020)
13.8.5 Becton Dickinson Recent Development
13.9 BG Medicine
13.9.1 BG Medicine Company Details
13.9.2 BG Medicine Business Overview
13.9.3 BG Medicine Cardiomyopathy Introduction
13.9.4 BG Medicine Revenue in Cardiomyopathy Business (2015-2020)
13.9.5 BG Medicine Recent Development
13.10 BioMérieux
13.10.1 BioMérieux Company Details
13.10.2 BioMérieux Business Overview
13.10.3 BioMérieux Cardiomyopathy Introduction
13.10.4 BioMérieux Revenue in Cardiomyopathy Business (2015-2020)
13.10.5 BioMérieux Recent Development
13.11 Bio-Rad
10.11.1 Bio-Rad Company Details
10.11.2 Bio-Rad Business Overview
10.11.3 Bio-Rad Cardiomyopathy Introduction
10.11.4 Bio-Rad Revenue in Cardiomyopathy Business (2015-2020)
10.11.5 Bio-Rad Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cardiomyopathy Key Market Segments
Table 2. Key Players Covered: Ranking by Cardiomyopathy Revenue
Table 3. Ranking of Global Top Cardiomyopathy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cardiomyopathy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Dilated cardiomyopathy
Table 6. Key Players of Hypertrophic cardiomyopathy
Table 7. Key Players of Restrictive cardiomyopathy
Table 8. Global Cardiomyopathy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Cardiomyopathy Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Cardiomyopathy Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Cardiomyopathy Market Share by Regions (2015-2020)
Table 12. Global Cardiomyopathy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Cardiomyopathy Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Cardiomyopathy Market Growth Strategy
Table 18. Main Points Interviewed from Key Cardiomyopathy Players
Table 19. Global Cardiomyopathy Revenue by Players (2015-2020) (Million US$)
Table 20. Global Cardiomyopathy Market Share by Players (2015-2020)
Table 21. Global Top Cardiomyopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiomyopathy as of 2019)
Table 22. Global Cardiomyopathy by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cardiomyopathy Product Solution and Service
Table 25. Date of Enter into Cardiomyopathy Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 28. Global Cardiomyopathy Market Size Share by Type (2015-2020)
Table 29. Global Cardiomyopathy Revenue Market Share by Type (2021-2026)
Table 30. Global Cardiomyopathy Market Size Share by Application (2015-2020)
Table 31. Global Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 32. Global Cardiomyopathy Market Size Share by Application (2021-2026)
Table 33. North America Key Players Cardiomyopathy Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Cardiomyopathy Market Share (2019-2020)
Table 35. North America Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 36. North America Cardiomyopathy Market Share by Type (2015-2020)
Table 37. North America Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 38. North America Cardiomyopathy Market Share by Application (2015-2020)
Table 39. Europe Key Players Cardiomyopathy Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Cardiomyopathy Market Share (2019-2020)
Table 41. Europe Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Cardiomyopathy Market Share by Type (2015-2020)
Table 43. Europe Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Cardiomyopathy Market Share by Application (2015-2020)
Table 45. China Key Players Cardiomyopathy Revenue (2019-2020) (Million US$)
Table 46. China Key Players Cardiomyopathy Market Share (2019-2020)
Table 47. China Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 48. China Cardiomyopathy Market Share by Type (2015-2020)
Table 49. China Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 50. China Cardiomyopathy Market Share by Application (2015-2020)
Table 51. Japan Key Players Cardiomyopathy Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Cardiomyopathy Market Share (2019-2020)
Table 53. Japan Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Cardiomyopathy Market Share by Type (2015-2020)
Table 55. Japan Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Cardiomyopathy Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Cardiomyopathy Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Cardiomyopathy Market Share (2019-2020)
Table 59. Southeast Asia Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Cardiomyopathy Market Share by Type (2015-2020)
Table 61. Southeast Asia Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Cardiomyopathy Market Share by Application (2015-2020)
Table 63. India Key Players Cardiomyopathy Revenue (2019-2020) (Million US$)
Table 64. India Key Players Cardiomyopathy Market Share (2019-2020)
Table 65. India Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 66. India Cardiomyopathy Market Share by Type (2015-2020)
Table 67. India Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 68. India Cardiomyopathy Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Cardiomyopathy Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Cardiomyopathy Market Share (2019-2020)
Table 71. Central & South America Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Cardiomyopathy Market Share by Type (2015-2020)
Table 73. Central & South America Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Cardiomyopathy Market Share by Application (2015-2020)
Table 75. Array BioPharma Company Details
Table 76. Array BioPharma Business Overview
Table 77. Array BioPharma Product
Table 78. Array BioPharma Revenue in Cardiomyopathy Business (2015-2020) (Million US$)
Table 79. Array BioPharma Recent Development
Table 80. Boston Scientific Company Details
Table 81. Boston Scientific Business Overview
Table 82. Boston Scientific Product
Table 83. Boston Scientific Revenue in Cardiomyopathy Business (2015-2020) (Million US$)
Table 84. Boston Scientific Recent Development
Table 85. Cisbio Company Details
Table 86. Cisbio Business Overview
Table 87. Cisbio Product
Table 88. Cisbio Revenue in Cardiomyopathy Business (2015-2020) (Million US$)
Table 89. Cisbio Recent Development
Table 90. Covance Company Details
Table 91. Covance Business Overview
Table 92. Covance Product
Table 93. Covance Revenue in Cardiomyopathy Business (2015-2020) (Million US$)
Table 94. Covance Recent Development
Table 95. Critical Diagnostics Company Details
Table 96. Critical Diagnostics Business Overview
Table 97. Critical Diagnostics Product
Table 98. Critical Diagnostics Revenue in Cardiomyopathy Business (2015-2020) (Million US$)
Table 99. Critical Diagnostics Recent Development
Table 100. Mylan Company Details
Table 101. Mylan Business Overview
Table 102. Mylan Product
Table 103. Mylan Revenue in Cardiomyopathy Business (2015-2020) (Million US$)
Table 104. Mylan Recent Development
Table 105. Pfizer Company Details
Table 106. Pfizer Business Overview
Table 107. Pfizer Product
Table 108. Pfizer Revenue in Cardiomyopathy Business (2015-2020) (Million US$)
Table 109. Pfizer Recent Development
Table 110. Becton Dickinson Business Overview
Table 111. Becton Dickinson Product
Table 112. Becton Dickinson Company Details
Table 113. Becton Dickinson Revenue in Cardiomyopathy Business (2015-2020) (Million US$)
Table 114. Becton Dickinson Recent Development
Table 115. BG Medicine Company Details
Table 116. BG Medicine Business Overview
Table 117. BG Medicine Product
Table 118. BG Medicine Revenue in Cardiomyopathy Business (2015-2020) (Million US$)
Table 119. BG Medicine Recent Development
Table 120. BioMérieux Company Details
Table 121. BioMérieux Business Overview
Table 122. BioMérieux Product
Table 123. BioMérieux Revenue in Cardiomyopathy Business (2015-2020) (Million US$)
Table 124. BioMérieux Recent Development
Table 125. Bio-Rad Company Details
Table 126. Bio-Rad Business Overview
Table 127. Bio-Rad Product
Table 128. Bio-Rad Revenue in Cardiomyopathy Business (2015-2020) (Million US$)
Table 129. Bio-Rad Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cardiomyopathy Market Share by Type: 2020 VS 2026
Figure 2. Dilated cardiomyopathy Features
Figure 3. Hypertrophic cardiomyopathy Features
Figure 4. Restrictive cardiomyopathy Features
Figure 5. Global Cardiomyopathy Market Share by Application: 2020 VS 2026
Figure 6. Hospitals and diagnostic centers Case Studies
Figure 7. Ambulatory services centers Case Studies
Figure 8. Cardiomyopathy Report Years Considered
Figure 9. Global Cardiomyopathy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Cardiomyopathy Market Share by Regions: 2020 VS 2026
Figure 11. Global Cardiomyopathy Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Cardiomyopathy Market Share by Players in 2019
Figure 14. Global Top Cardiomyopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiomyopathy as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Cardiomyopathy Revenue in 2019
Figure 16. North America Cardiomyopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Cardiomyopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Cardiomyopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Cardiomyopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Cardiomyopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Cardiomyopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Cardiomyopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
肥大型心筋症治療薬の世界市場（～2026年） HCM is the enlargement of the heart muscle (myocardium), which disrupts the functions of the heart. HCM is mostly caused due to gene mutation and is a significant cause of sudden cardiac death in any age group. Hypertrophy is defined as an enlargement of a tissue or organ, and cardiomyopathy refers …- 拡張型心筋症の世界市場（～2026年） Dilated Cardiomyopathy (DCM) refers to the cardiac hypertrophy, cannot effectively pump blood. Dilated Cardiomyopathy (DCM) is due to genetic or other disease caused by a heart disease, it respectively affect the ventricles of the heart and heart, the inferior vena chamber and the upper Chambers of …
- 拡張型心筋症治療の世界市場（～2026年） Dilated Cardiomyopathy (DCM) is a condition in which heart's left ventricle, is enlarged and weakened and the ability to pump blood is decreased. The growth in DCM treatment market is due to prominent rise in number of heart failure patients worldwide over the years, R&D activities and increased awa…
- 肥大型心筋症（HCM）治療薬の世界市場（～2026年） Hypertrophic Cardiomyopathy (HCM) is a condition in which a portion of the heart becomes thickened without an obvious cause. This results in the heart being less able to pump blood effectively. Symptoms vary from none to feeling tired, leg swelling, and shortness of breath. It may also result in che…
- 家族/屋内エンターテイメントセンターの世界市場（～2026年） With continuous innovations in technological aspects, family entertainment centres are offering a diversified range of gaming options for their customers. New technologies such as virtual reality gaming, 3D technology, etc. are trending and consumers are preferring modern ways of entertainment over …